Virtual Realityon Pain, Anxiety and Comfort During Trigger Point Injection

NCT06140368 | Completed

• 1 other identifier: BU-SBF-EI-003
• Study Type: interventional
• Target: 84
• Locations: 1 country
• Sites: 1

Brief Summary

To determine the effects of virtual reality application during trigger point injection on patients' pain, anxiety and comfort levels.This research was planned as a randomized controlled experimental type. The population of the research was planned to include patients who applied to the Algology polyclinic for trigger point injection. The sample of the research will consist of 150 patients who meet the sampling criteria and agree to participate in the research.Inclusion criteria: Trigger point injection applied for the first time, 18 years and over, understand and speak Turkish, understand verbal and written information given.Patients will be divided into two groups: experimental (virtual reality) and control groups.Data will be collected with the Case Report Form, State Anxiety Scale, General Comfort Scale and Visual Analog Scale.Patients' anxiety, comfort and pain levels will be evaluated before and after trigger point injection.

Conditions

Virtual Reality

Keywords

virtual reality; pain; trigger point injection.; anxiety; comfort

Outcome Measures

Primary Outcomes (3)

• State Anxiety Scale

  The scale developed by Spielberger et al. aims to measure state and trait anxiety levels separately.The scores obtained from the scale vary between 20-80, and the total score between 20-39 indicates mild anxiety, between 40-59 indicates moderate anxiety, and between 60-79 indicates severe anxiety.

  10 minutes after procedure

• General Comfort Scale

  The scale, which was developed by Kolcaba in 2006 and has a total of 28 questions as 'Refreshing (9 items), Relaxation (9 items) and Overcoming Problems (10 items), consists of three sub-dimensions.The lowest value that can be taken is 1, which indicates low comfort, and the highest value, 6, indicates high comfort.

  10 minutes after procedure

• Visual Analog Scale

  It is aimed to determine the level of pain.0 means no pain and 10 means maximum pain

  In the middle (10 minutes) of the procedure

Study Arms (2)

Experimental group

EXPERIMENTAL

During the trigger point injection, patients will be shown videos that the patient wants to watch, such as nature and seaside walks, underwater videos, with music background, through virtual reality glasses for 10 minutes.

Behavioral: virtual reality

Control group

NO INTERVENTION

Patients will not use virtual reality glasses during trigger point injection.

Interventions

virtual reality BEHAVIORAL

During the trigger point injection, patients will be shown videos that the patient wants to watch, such as nature and seaside walks, underwater videos, with music background, through virtual reality glasses for 10 minutes.

Experimental group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• The procedure will be applied for the first time
• years and over
• Able to understand and speak Turkish
• Able to understand verbal and written information given
• Having good cognitive abilities
• Without visual or hearing loss
• Patients who agreed to participate in the study

You may not qualify if:

• Those who do not understand or speak Turkish
• Does not understand verbal and written information
• Those with impaired cognitive abilities
• Epilepsy

Sponsors & Collaborators

• Izmir Bakircay University: lead

Study Sites (1)

Elif Günay İsmailoğlu

Izmir, Menemen, 35160, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain; Anxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Mental Disorders

Study Officials

• Elif Günay İsmailoğlu

  Izmir Bakircay University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: CARE PROVIDER
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: November 10, 2023
• First Posted: November 20, 2023
• Study Start: May 10, 2023
• Primary Completion: August 10, 2023
• Study Completion: December 10, 2023
• Last Updated: December 12, 2025

Record last verified: 2025-12

Locations

TU (1)